These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 21852609

  • 1. Safety of Tirofiban in acute Ischemic Stroke: the SaTIS trial.
    Siebler M, Hennerici MG, Schneider D, von Reutern GM, Seitz RJ, Röther J, Witte OW, Hamann G, Junghans U, Villringer A, Fiebach JB.
    Stroke; 2011 Sep; 42(9):2388-92. PubMed ID: 21852609
    [Abstract] [Full Text] [Related]

  • 2. Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial.
    Torgano G, Zecca B, Monzani V, Maestroni A, Rossi P, Cazzaniga M, Manganaro D, Boiti C, Zilioli E, Borutti G, Falaschi F, Mandelli C.
    Cerebrovasc Dis; 2010 Feb; 29(3):275-81. PubMed ID: 20090319
    [Abstract] [Full Text] [Related]

  • 3. Safety and Preliminary Efficacy of Early Tirofiban Treatment After Alteplase in Acute Ischemic Stroke Patients.
    Li W, Lin L, Zhang M, Wu Y, Liu C, Li X, Huang S, Liang C, Wang Y, Chen J, Feng W.
    Stroke; 2016 Oct; 47(10):2649-51. PubMed ID: 27608821
    [Abstract] [Full Text] [Related]

  • 4. Effects of Oral Antiplatelet Agents and Tirofiban on Functional Outcomes of Patients with Non-Disabling Minor Acute Ischemic Stroke.
    Wang H, Li X, Liu C, Huang S, Liang C, Zhang M.
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104829. PubMed ID: 32689578
    [Abstract] [Full Text] [Related]

  • 5. Effect of Intravenous Tirofiban vs Placebo Before Endovascular Thrombectomy on Functional Outcomes in Large Vessel Occlusion Stroke: The RESCUE BT Randomized Clinical Trial.
    RESCUE BT Trial Investigators, Qiu Z, Li F, Sang H, Luo W, Liu S, Liu W, Guo Z, Li H, Sun D, Huang W, Zhang M, Zhang M, Dai W, Zhou P, Deng W, Zhou Z, Huang X, Lei B, Li J, Yuan Z, Song B, Miao J, Liu S, Jin Z, Zeng G, Zeng H, Yuan J, Wen C, Yu Y, Yuan G, Wu J, Long C, Luo J, Tian Z, Zheng C, Hu Z, Wang S, Wang T, Qi L, Li R, Wan Y, Ke Y, Wu Y, Zhu X, Kong W, Huang J, Peng D, Chang M, Ge H, Shi Z, Yan Z, Du J, Jin Y, Ju D, Huang C, Hong Y, Liu T, Zhao W, Wang J, Zheng B, Wang L, Liu S, Luo X, Luo S, Xu X, Hu J, Pu J, Chen S, Sun Y, Jiang S, Wei L, Fu X, Bai Y, Yang S, Hu W, Zhang G, Pan C, Zhang S, Wang Y, Cao W, Yang S, Zhang J, Guo F, Wen H, Zhang J, Song J, Yue C, Li L, Wu D, Tian Y, Yang J, Lu M, Saver JL, Nogueira RG, Zi W, Yang Q.
    JAMA; 2022 Aug 09; 328(6):543-553. PubMed ID: 35943471
    [Abstract] [Full Text] [Related]

  • 6. Abciximab in acute ischemic stroke. A randomized, double-blind, placebo-controlled, dose-escalation study.
    Abciximab in Ischemic Stroke InvestigatorsDepartment of Neurology, University of Iowa, Iowa City 52242-1053, USA..
    Stroke; 2000 Mar 09; 31(3):601-9. PubMed ID: 10700492
    [Abstract] [Full Text] [Related]

  • 7. Bleeding risk of tirofiban, a nonpeptide GPIIb/IIIa platelet receptor antagonist in progressive stroke: an open pilot study.
    Junghans U, Seitz RJ, Aulich A, Freund HJ, Siebler M.
    Cerebrovasc Dis; 2001 Mar 09; 12(4):308-12. PubMed ID: 11721100
    [Abstract] [Full Text] [Related]

  • 8. Safety and preliminary efficacy of intravenous tirofiban in acute ischemic stroke patient without arterial occlusion on neurovascular imaging studies.
    Lin L, Li W, Liu CC, Wu Y, Huang SH, Li XS, Liang CR, Wang H, Zhang LL, Xu ZQ, Wang YJ, Feng W, Zhang M.
    J Neurol Sci; 2017 Dec 15; 383():175-179. PubMed ID: 29246609
    [Abstract] [Full Text] [Related]

  • 9. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
    Heiss WD, Brainin M, Bornstein NM, Tuomilehto J, Hong Z, Cerebrolysin Acute Stroke Treatment in Asia (CASTA) Investigators.
    Stroke; 2012 Mar 15; 43(3):630-6. PubMed ID: 22282884
    [Abstract] [Full Text] [Related]

  • 10. Treatment of progressive stroke with tirofiban--experience in 35 patients.
    Philipps J, Thomalla G, Glahn J, Schwarze M, Rother J.
    Cerebrovasc Dis; 2009 Mar 15; 28(5):435-8. PubMed ID: 19738371
    [Abstract] [Full Text] [Related]

  • 11. Tirofiban for Stroke without Large or Medium-Sized Vessel Occlusion.
    Zi W, Song J, Kong W, Huang J, Guo C, He W, Yu Y, Zhang B, Geng W, Tan X, Tian Y, Liu Z, Cao M, Cheng D, Li B, Huang W, Liu J, Wang P, Yu Z, Liang H, Yang S, Tang M, Liu W, Huang X, Liu S, Tang Y, Wu Y, Yao L, Shi Z, He P, Zhao H, Chen Z, Luo J, Wan Y, Shi Q, Wang M, Yang D, Chen X, Huang F, Mu J, Li H, Li Z, Zheng J, Xie S, Cai T, Peng Y, Xie W, Qiu Z, Liu C, Yue C, Li L, Tian Y, Yang D, Miao J, Yang J, Hu J, Nogueira RG, Wang D, Saver JL, Li F, Yang Q, RESCUE BT2 Investigators.
    N Engl J Med; 2023 Jun 01; 388(22):2025-2036. PubMed ID: 37256974
    [Abstract] [Full Text] [Related]

  • 12. Ischemic brain tissue salvaged from infarction by the GP IIb/IIIa platelet antagonist tirofiban.
    Junghans U, Seitz RJ, Ritzl A, Wittsack HJ, Fink GR, Freund HJ, Siebler M.
    Neurology; 2002 Feb 12; 58(3):474-6. PubMed ID: 11839855
    [Abstract] [Full Text] [Related]

  • 13. CT-based intravenous thrombolysis 3-4.5 hours after acute ischemic stroke in clinical practice.
    Sarikaya H, Fischer A, Valko PO, Weck A, Braun J, Georgiadis D, Baumgartner RW.
    Neurol Res; 2011 Sep 12; 33(7):701-7. PubMed ID: 21756549
    [Abstract] [Full Text] [Related]

  • 14. Tirofiban for acute ischemic stroke: systematic review and meta-analysis.
    Gong J, Shang J, Yu H, Wan Q, Su D, Sun Z, Liu G.
    Eur J Clin Pharmacol; 2020 Apr 12; 76(4):475-481. PubMed ID: 31900544
    [Abstract] [Full Text] [Related]

  • 15. Safety and feasibility of intraarterial eptifibatide as a revascularization tool in acute ischemic stroke.
    Memon MZ, Natarajan SK, Sharma J, Mathews MS, Snyder KV, Siddiqui AH, Hopkins LN, Levy EI.
    J Neurosurg; 2011 Apr 12; 114(4):1008-13. PubMed ID: 20868216
    [Abstract] [Full Text] [Related]

  • 16. Intravenous tirofiban with intra-arterial urokinase and mechanical thrombolysis in stroke: preliminary experience in 11 cases.
    Mangiafico S, Cellerini M, Nencini P, Gensini G, Inzitari D.
    Stroke; 2005 Oct 12; 36(10):2154-8. PubMed ID: 16141418
    [Abstract] [Full Text] [Related]

  • 17. [Efficacy and safety of treatment of acute ischemic stroke with glycoprotein IIb/IIIa receptor blocker in routine clinical practice].
    Haerten K, Krabbe C, Raiber M.
    Dtsch Med Wochenschr; 2004 Mar 19; 129(12):607-10. PubMed ID: 15011129
    [Abstract] [Full Text] [Related]

  • 18. Benefits and safety of tirofiban among acute coronary syndrome patients with mild to moderate renal insufficiency: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial.
    Januzzi JL, Snapinn SM, DiBattiste PM, Jang IK, Theroux P.
    Circulation; 2002 May 21; 105(20):2361-6. PubMed ID: 12021221
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and Safety of Low-Dose Tirofiban for Acute Intracranial Atherosclerotic Stenosis Related Occlusion with Residual Stenosis after Endovascular Treatment.
    Yan Z, Shi Z, Wang Y, Zhang C, Cao J, Ding C, Qu M, Xia Y, Cai J, Zhang X, Wang H.
    J Stroke Cerebrovasc Dis; 2020 Apr 21; 29(4):104619. PubMed ID: 31982305
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.